PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
-2.01%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$148M
AUM Growth
+$148M
(-12%)
Cap. Flow
+$9.37M
Cap. Flow
% of AUM
6.33%
Top 10 Holdings %
Top 10 Hldgs %
99.46%
Holding
12
New
1
Increased
4
Reduced
–
Closed
1
Top Buys
| 1 |
Vaxcyte
PCVX
|
$5.26M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
$4.03M |
| 3 |
Oculis Holding
OCS
|
$2.41M |
| 4 |
BIOA
BioAge Labs, Inc. Common Stock
BIOA
|
$728K |
| 5 |
ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
|
$704K |
Top Sells
| 1 |
EXAI
Exscientia Plc American Depositary Shares
EXAI
|
$3.76M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vaxcyte
PCVX
$4B
| $57.6M | 38.91% | 703,834 +64,295 | +10% | +$5.26M |
|
|
2
Oculis Holding
OCS
$844M
| $29.5M | 19.95% | 1,737,696 +141,778 | +9% | +$2.41M |
|
3
Arcutis Biotherapeutics
ARQT
$1.86B
| $29.5M | 19.95% | 2,120,508 | – | – |
|
|
INZY
4
DELISTED
Inozyme Pharma
INZY
| $12.5M | 8.41% | 4,494,851 | – | – |
|
|
ZBIO
5
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $6.03M | 4.07% | 736,645 +85,950 | +13% | +$704K |
|
|
6
Recursion Pharmaceuticals
RXRX
$2.04B
| $4.03M | 2.72% | +595,518 | New | +$4.03M |
|
|
BIOA
7
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $3.78M | 2.56% | 653,374 +125,727 | +24% | +$728K |
|
8
Rallybio
RLYB
$22.4M
| $2.31M | 1.56% | 2,404,644 | – | – |
|
9
Bolt Biotherapeutics
BOLT
$9.85M
| $1.02M | 0.69% | 1,891,467 | – | – |
|
|
VIGL
10
DELISTED
Vigil Neuroscience
VIGL
| $953K | 0.64% | 560,595 | – | – |
|
11
IO Biotech
IOBT
$104M
| $795K | 0.54% | 864,197 | – | – |
|
|
EXAI
12
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| – | – | -770,500 | Closed | -$3.76M |
|